The global polyclonal antibody market is poised for steady expansion through 2034, driven by increasing demand for diagnostic tools, therapeutic applications, and advanced research solutions. Valued at US$ 1.1 Bn in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2034, reaching an estimated US$ 2.0 Bn by the end of the forecast period....